Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

205

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

205 results for “safety factor”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov40/100

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/H

ClinicalTrials.gov study NCT02049957. IPD Sharing: YES. Countries: 3. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

ClinicalTrials.gov study NCT01410227. IPD Sharing: YES. Countries: 16. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients

ClinicalTrials.gov study NCT00157157. IPD Sharing: YES. Countries: 10. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A

ClinicalTrials.gov study NCT02234323. IPD Sharing: YES. Countries: 14. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV00

ClinicalTrials.gov study NCT03205163. IPD Sharing: YES. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

ClinicalTrials.gov study NCT01151423. IPD Sharing: YES. Countries: 13. Publications: 3.

controlledIPD-YESFeb 2026View details →
dryad36/100

Factors related to the implementation of patient safety culture in prehospital emergency services

<p><span>Background</span><span>: Prehospital emergency services are one of the main areas of health care, which provide emergency services for patients who experience acute, critical illness or injury outside the hospital. Prehospital services are more often carried out by the Emergency Medical Services (EMS) team, as one of the health service providers who come to the scene more quickly, both in daily emergencies.</span></p> <p><span>Purpose</span><span>: </span><span>This study aims to determine the factors related to the application of patient safety culture and determine the most dominant factors in the application of patient safety culture at </span><span>the prehospital emergency service in Bantaeng.</span></p> <p><span>Results:</span><span> The results showed that all domains of patient safety culture had a significant effect (p&lt;0.05) namely teamwork 0.000, safety climate 0.000, management perception and support 0.000, job satisfaction 0.019, work environment 0.000 and stress recognition 0.000. The most influential domain is stress recognition 1.116 and Adjust R Square value of 69.7%.</span></p> <p><span>Conclusion:</span><span> Patient safety needs to be a priority in handling and organizations must continue to evaluate the application of patient safety culture in PSC 119 setting in Bantaeng. Nurses are responsible for improving services that prioritize patient safety by understanding all factors related to the implementation of patient safety culture.</span></p>

opencc-zeroJun 2022View details →
zenodo36/100

Assessment of Patient Safety Culture and Associated Factors among Healthcare Professionals in Public Hospitals of Bahir Dar City, Northwest Ethiopia: A Mixed-Methods Study

<p>This data set contains HSOPSC&nbsp; on the <span>Assessment of Patient Safety Culture and Associated Factors among Healthcare Professionals in Public Hospitals of Bahir Dar City, Northwest Ethiopia: A Mixed-Methods Study</span></p>

opencc-by-4.0Sep 2024View details →
zenodo36/100

Assessment of Patient Safety Culture and Associated Factors among Healthcare Professionals in Public Hospitals of Bahir Dar City, Northwest Ethiopia: A Mixed-Methods Study

<p><span>This dataset contains raw data on "regression analyses" on&nbsp; the assessment of patient safety culture among healthcare professionals in public hospitals of Bahir Dar City, Northwest Ethiopia."</span></p>

opencc-by-4.0Sep 2024View details →
zenodo36/100

Assessment of Patient Safety Culture and Associated Factors among Healthcare Professionals in Public Hospitals of Bahir Dar City, Northwest Ethiopia: A Mixed-Methods Study

<p><span>This dataset contains raw data&nbsp; of " </span><span>Likert Scale Descriptive Analysis"on t</span><span>he assessment of patient safety culture among healthcare professionals in public hospitals of Bahir Dar City, Northwest Ethiopia.</span></p>

opencc-by-4.0Sep 2024View details →
ClinicalTrials.gov36/100

A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors

ClinicalTrials.gov study NCT02136069. IPD Sharing: YES. Countries: 20. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

ClinicalTrials.gov study NCT02538341. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Local

ClinicalTrials.gov study NCT02924883. IPD Sharing: Not stated. Countries: 9. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer

ClinicalTrials.gov study NCT03451162. IPD Sharing: Not stated. Countries: 2. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

ClinicalTrials.gov study NCT01012973. IPD Sharing: Not stated. Countries: 10. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A

ClinicalTrials.gov study NCT01458106. IPD Sharing: Not stated. Countries: 8. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents

ClinicalTrials.gov study NCT00516386. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel Versus Placebo + Trastuzumab + Docetaxel in Previously Untreated Human Epidermal Growth Factor Receptor 2 (HER2)-Pos

ClinicalTrials.gov study NCT02896855. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa

ClinicalTrials.gov study NCT02448680. IPD Sharing: NO. Countries: 6. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A

ClinicalTrials.gov study NCT01181128. IPD Sharing: Not stated. Countries: 19. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record